Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY
26/02/2026 11:26
Feb 26 (Reuters) - China NT Pharma Group Co Ltd 1011.HK: EXPECTED TO RECORD A NET LOSS ATTRIBUTABLE OF RMB25.0 MILLION TO RMB30.0 MILLION IN FY EXPECTED RESULT DUE TO ONE- OFF NON-CASH FAIR VALUE LOSS IN FY, OTHERS Further company coverage: 1011.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY